Changes in Blood Profile from Steady State in Patients with Sickle Cell Anemia Admitted for Vaso-occlusive Crisis and Acute Chest Syndrome

Close to half of all patients with sickle cell disease (SCD) will have at least one episode of acute chest syndrome (ACS) during their lifetime. Multiple cells and molecules involved with the inflammatory cascade play a role in the development of ACS. We found that patients with SCD who developed AC...

Full description

Saved in:
Bibliographic Details
Published in:Advances in hematology 2020, Vol.2020 (2020), p.1-5
Main Authors: Apollonsky, Nataly, Bernstein, Bruce, Raybagkar, Deepti, Klouda, Timothy
Format: Article
Language:English
Subjects:
Asthma
Blood
Blood platelets
Endothelium
Genotype & phenotype
Hemoglobin
Inflammation
Laboratories
Oxygen saturation
Patients
Pediatrics
Pneumonia
Risk factors
Sickle cell anemia
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Close to half of all patients with sickle cell disease (SCD) will have at least one episode of acute chest syndrome (ACS) during their lifetime. Multiple cells and molecules involved with the inflammatory cascade play a role in the development of ACS. We found that patients with SCD who developed ACS as a complication of a vaso-occlusive crisis (VOC) had a significant increase in leukocytes and decrease in platelets from their steady state when compared with a separate admission for VOC without ACS development. No significant change from steady state hemoglobin or reticulocyte count was noted between the two admissions. These results indicate that trending laboratory markers may be useful to predict patients at risk for ACS development.
ISSN:1687-9104
1687-9112
DOI:10.1155/2020/3656717